 Taysha Gene Therapies, Inc. NASDAQ:TSHA Q1 2022 Earnings Conference Call May 16, 2022 8:00 AM ET Company Participants Kimberly Lee - Chief Corporate Affairs Officer RA Session II - President, Founder, and Chief Executive Officer Suyash Prasad - Chief Medical Officer and Head, RD Kamran Alam - Chief Financial Officer Conference Call Participants Gil Blum - Needham Company Elizabeth Webster - Goldman Sachs Kevin DeGeeter - Oppenheimer Company Jack Allen - Baird Yun Zhong - BTIG Laura Chico - Wedbush Securities Yanan Zhu - Wells Fargo Operator Good morning. Welcome to Taysha Gene Therapies First Quarter 2022 Financial Results and Corporate Update Conference Call. 